Marshall Wace, LLP Vanda Pharmaceuticals Inc. Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

A detailed history of Marshall Wace, LLP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 66,645 shares of VNDA stock, worth $376,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,645

Previous 187,497 64.46%

Holding current value

$376,544

Previous $791,000 65.49%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$3.47 - $4.61 $419,356 - $557,127	-120,852 Reduced 64.46%	66,645 $273,000
Q4 2023 Feb 14, 2024	BUY	$3.38 - $4.58 $633,739 - $858,736	187,497 New	187,497 $791,000
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $35,806 - $45,536	-3,846 Reduced 23.08%	12,818 $140,000
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $180,637 - $275,789	16,664 New	16,664 $189,000
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $1.62 Million - $2.45 Million	-121,010 Closed	0 $0

Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $1.5 Million - $2.12 Million	-153,844 Reduced 55.97%	121,010 $1.59 Million
Q3 2020 Nov 16, 2020	BUY	$9.32 - $12.02 $1.62 Million - $2.09 Million	174,061 Added 172.69%	274,854 $2.66 Million
Q2 2020 Aug 13, 2020	SELL	$9.66 - $12.02 $5.28 Million - $6.57 Million	-546,667 Reduced 84.43%	100,793 $1.15 Million
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $1.39 Million - $3.12 Million	185,769 Added 40.24%	647,460 $6.71 Million
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $56,279 - $79,418	4,546 Added 0.99%	461,691 $7.58 Million
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $4.98 Million - $6.41 Million	405,975 Added 793.38%	457,145 $6.07 Million
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $683,955 - $964,290	51,156 Added 365400.0%	51,170 $721,000
Q1 2019 May 14, 2019	BUY	$17.59 - $31.05 $246 - $434	14 New	14 $0
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $1.65 Million - $2.73 Million	-86,835 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $1.58 Million - $2 Million	86,835 New	86,835 $1.99 Million

Others Institutions Holding VNDA

# of Institutions

147

Shares Held

49.6M

Call Options Held

49.1K

Put Options Held

107K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $320M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Vanda Pharmaceuticals Inc. Transaction History